Dassault Systemes and Inserm link up with aim of deciphering disease complexity

Published: 29-Mar-2016
Research & Development Digital

The agreement will draw from the expertise of each organisation to offer new perspectives for addressing scientific and health challenges


Dassault Systemes, a French specialist in 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions, has signed an agreement with the French National Institute of Health and Medical Research (Inserm), to accelerate clinical research programmes using a virtual collaborative platform. The agreement will draw from the expertise of each organisation to offer new perspectives for addressing scientific and health challenges.

Inserm will use Dassault Systèmes’ 3DEXPERIENCE technology to conduct its biomedical research programmes in the areas of ageing, cancer, genomics and microbiota. The platform provides Inserm with an integrated virtual environment for open collaborative research, unified laboratory management and biological and chemical modelling and simulation from Dassault Systèmes’ BIOVIA flagship brand.

In turn, Dassault Systèmes will leverage big data from Inserm’s research programmes to calibrate and validate scientific models that can be applied to future technologies for clinical research. These models will enable the company to develop next-generation industry solutions targeting clinical trials, to accelerate decision-making and to enable earlier efficacy and safety demonstration with virtual trials.

'We seek out technologies that further our mission to observe and understand mechanisms of the living body and ultimately transfer this knowledge to therapeutic solutions for new and mutating diseases that are affecting the world’s growing population,' said Professor Yves Lévy, Chairman and CEO, Inserm. 'We lead long-term, competitive scientific programmes in human health and medicine and the Dassault Systèmes’ 3DEXPERIENCE platform will help us support collaboration, project management, data, resources, traceability and other processes.'

Bernard Charlès, President & CEO, Dassault Systèmes, said: 'This fusion of advanced clinical research and the virtual world is a stepping stone to the future of precision medicine and brings us closer to harmonising product, nature and life.'

  • Companies:
  • Dassault Systems
See more

You may also like

Manufacturing

What is MES and why should manufacturers invest in it?

Read more
A manufacturing execution system, often referred to as MES, has quickly become a staple within many businesses around the globe. Offering manufacturers a dynamic software solution that is capable of monitoring, tracking, controlling and documenting manufactured products throughout production, MES provides key decision makers with all of the information they require to implement efficiency driven changes to their operations

Trending Articles

  1. Sartorius Stedim Biotech supports bioprocess development with new Innovation Centre The Massachusetts, US-based Centre for Bioprocess Innovation is a collaborative space designed to develop and optimise biomanufacturing processes
  2. Aurobindo Pharma signs $25m respiratory drug development and commercialisation deal with global pharma company The companies will co-develop and commercialise respiratory therapeutics, diversifying Aurobindo's current portfolio
  3. Steritas and argenx join forces to advance steroid-sparing therapeutic development With the help of Steritas' STOX Suite, argenx aims to develop antibody-based therapeutics for immune diseases, potentially allowing patients to move away from chronic steroid usage
  4. BioPharmaSpec expands its biopharma discovery and preclinical capabilities with three new facilities The contract research organisation (CRO) has expanded its European presence with three facilities, which are catered for biopharmaceutical drug discovery and preclinical characterisation
  5. Efficient PFAS-free degassing of aqueous solutions New silicone-based degassing chamber eliminates the risk of PFAS contamination

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

You may also like

Manufacturing

What is MES and why should manufacturers invest in it?

A manufacturing execution system, often referred to as MES, has quickly become a staple within many businesses around the globe. Offering manufacturers a dynamic software solution that is capable of monitoring, tracking, controlling and documenting manufactured products throughout production, MES provides key decision makers with all of the information they require to implement efficiency driven changes to their operations
Research & Development

Ipsen to use Dassault Systemes' software to support drug discovery

Selects the Designed to Cure platform, which offers data integration, modelling and simulation capabilities
Digital

Dassault Systemes launches software solutions for the life sciences

Aims to digitally transform the complex processes behind the design, development and production of new drugs
Hi Tech Manufacturing

Dassault Systemes and Accelrys to merge

Accelrys launches information management and collaboration workspace called ScienceCloud
Distribution

2BScientific expands its life science product supply service to Europe with new German facility

The facility in Munich will serve the European market with life science products, including in vitro diagnostic (IVD) reagents, buffers, biomaterials and antibodies
Digital

Why CGT manufacturers should automate the production process

Cell and gene therapies can be highly complex and time-consuming to produce at scale; full robotic automation could help biologics manufacturers to make processes more space, personnel and cost efficient
Manufacturing

Anton Paar expands Litesizer DIA Series with new models

Introducing affordable and advanced solutions for particle analysis
Subscribe now